Streetbeat News

Products Services

GTBIF

TCNNF

TSNDF

Ross Gerber, CEO of Gerber Kawasaki Wealth and Investment Management, will speak at the Benzinga Cannabis Capital Conference in Chicago, discussing the future of cannabis finance. Gerber, a long-time cannabis legalization advocate, will address challenges like tax issues and limited capital access, and the potential impact of federal rescheduling on the industry.

Portfolio Pulse from Javier Hasse

September 25, 2024 | 4:18 pm

FLGC

Flora Growth Corp. (NASDAQ:FLGC) has entered an exclusive distribution agreement with Canapuff to introduce its Vessel brand of cannabis accessories in the Czech Republic. This strategic move aims to strengthen Flora's market position in Europe.

Portfolio Pulse from Maureen Meehan

September 25, 2024 | 4:12 pm

SNAP

Snap has signed up to the EU's AI Pact, aligning with the EU's AI Act to promote trustworthy AI. Snap commits to adopting AI governance, mapping high-risk AI systems, and promoting AI literacy among staff.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 4:12 pm

GEV

Morgan Stanley analyst Andrew Percoco reiterated a Buy rating on GE Vernova stock, increasing the price target. He highlights GE Vernova as a strong solution for AI data centers, suggesting Wall Street may be recognizing its potential.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 4:10 pm

META

MSFT

QCOM

WMT

Meta Platforms is set to unveil new products at its Connect 2024 event, including the affordable Quest 3S headset and updates to its AI software. Analysts expect a focus on mixed reality and augmented reality, with potential AI product launches. A Walmart display leak suggests the Quest 3S will be priced at $299.99, featuring a Batman game bundle.

Portfolio Pulse from Anusuya Lahiri

September 25, 2024 | 4:03 pm

HSBC

HSBC's Chief Sustainability Officer, Herweijer, emphasized the importance of nuclear energy in the global energy transition and expressed support for governments' nuclear ambitions.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 4:02 pm

BMY

NVO

TSVT

2seventy bio and Bristol Myers Squibb have halted the Phase 3 trial of Abecma for newly diagnosed myeloma patients, aiming to save $80 million and reach profitability by 2025. Despite the trial halt, Abecma's revenue is expected to grow, supported by FDA approval for earlier use. Both companies share profits and losses from Abecma equally.

Portfolio Pulse from Vandana Singh

September 25, 2024 | 3:56 pm

UBSFY

Ubisoft has updated its financial targets for FY2024-25, with the release of Assassin's Creed Shadows set for February 14, 2025. The company expects Q2 FY2024-25 net bookings to be around €350-370 million.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 3:42 pm

CMI

DUK

GNRC

HD

HMC

TGT

WMT

Tropical Storm Helene is expected to become a hurricane as it approaches Florida, impacting stocks of generator producers, retailers, and utility companies with a presence in the state. Generac, Cummins, and Duke Energy saw slight declines, while Honda and Walmart experienced gains.

Portfolio Pulse from Michael Juliano

September 25, 2024 | 3:40 pm

TCNNF

Trulieve Cannabis Corp (OTC:TCNNF) is preparing for potential disruptions from Hurricane Helene as it approaches Florida. CEO Kim Rivers assures that the company is ready, with facilities built to withstand storms and generators on site. The storm poses a threat to Trulieve's operations and the cannabis supply chain, but the company is optimistic about its preparedness.

Portfolio Pulse from Javier Hasse

September 25, 2024 | 3:35 pm